dabuzalgron,
dabuzalgron hydrochloride,
Ro 115-1240,
Ro-115-1240,
Ro115-1240,
Dabuzalgron,
219311-44-1,
Ro-115-1240,
N-(6-Chloro-3-((4,5-dihydro-1H-imidazol-2-yl)methoxy)-2-methylphenyl)methanesulfonamide,
n-[6-chloro-3-(4,5-dihydro-1h-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide,
UNII-LGX4GZ74WO,
LGX4GZ74WO,
CHEMBL257978,
n-(6-chloro-3-((4,5-dihydro-1H-imidazol-2-yl)methoxy)-2-methyl phenyl)methanesulfonamide,
Dabuzalgron [INN],
Ro-1151240190,
dabuzalgronum,
AC1L50CX,
AC1Q6W48,
GTPL3469,
SCHEMBL5203336,
DTXSID50176345,
CHEBI:142452,
BDBM50377398,
ZINC49952320,
AKOS024257909,
AN-29530,
Ro 115-1240,
TX-013450,
R 450,
311D441,
A1-01879,
N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methyl-phenyl]methanesulfonamide,
D0Z3UP,
Alpha-1 adrenoceptor agonist, Roche,
AR-1K4245,
CID216249,
R-450,
23892-50-4,